Apparently, that "same old, same old" shareholder update has pushed my level of frustration with the SPL BoD to new highs...
And I thought I was a tough critic on management .... lol
So you think the pivot to address the market in India given its current overwhelming medical situation for COVID-19 sufferers outlined in the Shareholder Update is frustrating ?
Sure they still have to pull it off, but with Mundipharma already a distribution partner with an SPL7013 product, it shouldn't be that hard IMO during a pandemic killing thousands a day
SPL Price at posting:
$1.70 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)